(Q48338835)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Fingolimod effect on brain volume loss independently contributes to its effect on disability (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maria Pia Sormani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nicola De Stefano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

G Francis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

P Chin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E W Radue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L Kappos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

6 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

916-924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662353%20AND%20SRC:MED&resulttype=core&format=json

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Brain atrophy assessment in multiple sclerosis: importance and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Clinical relevance of brain volume measures in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Normalized accurate measurement of longitudinal brain change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Estimating the proportion of treatment effect explained by a surrogate marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Brain atrophy in multiple sclerosis: what we know and would like to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

The measurement and clinical relevance of brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458515569099